Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Buy
84,071
+77,599
+1,199% +$8.96M 0.03% 283
2026
Q1
$773K Buy
6,472
+1,286
+25% +$169K ﹤0.01% 709
2025
Q4
$706K Sell
5,186
-556
-10% -$80K ﹤0.01% 698
2025
Q3
$847K Buy
5,742
+505
+10% +$70K 0.01% 627
2025
Q2
$677K Buy
5,237
+1,140
+28% +$138K ﹤0.01% 639
2025
Q1
$489K Sell
4,097
-770
-16% -$95.4K ﹤0.01% 678
2024
Q4
$565K Sell
4,867
-181
-4% -$22.9K ﹤0.01% 840
2024
Q3
$682K Buy
5,048
+1,668
+49% +$223K 0.01% 764
2024
Q2
$458K Buy
3,380
+1,353
+67% +$184K ﹤0.01% 821
2024
Q1
$262K Buy
+2,027
New +$245K ﹤0.01% 943

Other funds holding XYL

Savant Capital's XYL Position: Q2 2026 in Review

Savant Capital increased its Xylem (XYL) stake by 1,199% in Q2 2026, buying an estimated $8.96M and bringing the position to 84,071 shares worth $10.2M. The position accounts for 0.03% of the portfolio, ranked #283.

Savant Capital first reported a position in XYL in Q1 2024 and has held it in 10 quarters since. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Savant Capital held 84,071 shares of Xylem worth $10.2M as of Q2 2026.
  • Savant Capital bought 77,599 Xylem shares in Q2 2026, an estimated $8.96M.
  • Xylem made up 0.03% of Savant Capital's portfolio in Q2 2026, its #283 holding.
  • Savant Capital first reported a position in Xylem in Q1 2024 and has held it in 10 quarters since.
  • 1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.